Details Basic Details Approval Date Tuesday, November 22, 2022 Original Posting Date Tuesday, January 23, 2024 Health Outcome(s) cytokine release syndrome, lymphoproliferative disorder, malignancy, serious infection, hypersensitivity reactions, adverse pregnancy and fetal outcomes Regulatory Link(s) (2) FDA Approval Package ARIA Memo